Cystic fibrosis drugs, including CFTR modulators and enzyme therapies, target the root genetic defect or manage thick mucus symptoms. These medications, taken orally or inhaled, improve lung function and digestion. They benefit individuals with specific CF mutations, particularly children and adults, by slowing disease progression and enhancing quality of life.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends